NEW YORK (GenomeWeb News) - Integrated Genomics said yesterday that it has signed an agreement with Danish food ingredients company Chr. Hansen to sequence the genome of an undisclosed probiotic lactic acid bacterium.
This contract extends an ongoing partnership between the companies in lactic acid microbial genomics. Chr. Hansen has also renewed its license to Integrated Genomics’ ERGO microbial genomics bioinformatics system, which it originally licensed in 2004.
Chr. Hansen scientists will use the sequence of the new genome along with ERGO to develop lactic acid bacteria used in foods and as probiotics for human health.
"We will use the information to get a better understanding of the organism in our processes, in those of our customers, as well as to understand the interaction between the probiotic lactic acid bacterium and the host, Eric Johansen, vice president of molecular microbiology at Chr. Hansen, said in a statement. “Ultimately we hope to understand how this specific microorganism provides its documented benefits and look for ways to further improve products containing this strain.”
The companies said they expect the sequencing project to run through 2006.